劉德亮 李惠林 渠昕
[摘要] 目的 研究活血降糖飲對2型糖尿病大鼠胰島β細(xì)胞凋亡的防治作用及對scrib蛋白表達(dá)的影響。 方法 通過高脂高熱卡飲食和小劑量鏈脲佐菌素尾靜脈注射誘導(dǎo)建立2型糖尿病模型大鼠,應(yīng)用SPSS軟件將模型大鼠隨機分為模型組、中藥組、雙胍組,另設(shè)正常組,每組各10只。藥物干預(yù)后檢測血脂、血糖及胰島素,并應(yīng)用原位末端標(biāo)記法檢測胰島β細(xì)胞凋亡情況;分離純化胰島細(xì)胞后,通過免疫印跡方法檢測各組大鼠胰島細(xì)胞scrib蛋白表達(dá)。 結(jié)果 與模型組比較,中藥組和雙胍組大鼠空腹血糖、餐后2 h血糖、空腹胰島素、餐后2 h胰島素、胰島素抵抗指數(shù)和總膽固醇、三酰甘油、低密度脂蛋白膽固醇均明顯下降,差異有統(tǒng)計學(xué)意義(P < 0.05或P < 0.01),而高密度脂蛋白膽固醇無明顯變化,差異無統(tǒng)計學(xué)意義(P > 0.05)。與模型組比較,中藥組和雙胍組大鼠胰島β細(xì)胞凋亡指數(shù)亦明顯降低(P < 0.01),胰島細(xì)胞scrib蛋白表達(dá)明顯上調(diào)(P < 0.01)。 結(jié)論 活血降糖飲干預(yù)治療具有調(diào)脂降糖、改善胰島素抵抗的作用,并可有效防治β細(xì)胞凋亡,其作用機制可能與上調(diào)胰島細(xì)胞scrib蛋白表達(dá)有關(guān)。
[關(guān)鍵詞] 活血降糖飲;2型糖尿??;細(xì)胞凋亡;Scrib;Hippo通路
[中圖分類號] R587.1 [文獻(xiàn)標(biāo)識碼] A [文章編號] 1673-7210(2018)11(c)-0004-05
The preventive effect of Huoxue Jiangtang Decoction on pancreatic β cell apoptosis and its influence on scrib protein expression in type 2 diabetes rats
LIU Deliang1 LI Huilin1 QU Xin1 ZHAO Hengxia1 CHU Shufang1 LIU Xuemei1 ZENG Lin2 ZHANG Xuewen2
1.Department of Endocrinology, Shenzhen Traditional Chinese Medicine Hospital, Guangdong Province, Shenzhen 518033, China; 2.the Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong Province, Shenzhen 518033, China; 3.Institute of Traditional Chinese Medicine Master, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China
[Abstract] Objective To investigate the preventive effect of Huoxue Jiangtang Decoction on pancreatic β cell apoptosis and its influence on scrib protein expression in type 2 diabetes mellitus rats. Methods The type 2 diabetes mellitus model was induced by high fat and high calorie diet and intravenous injection of low dose of Streptozotocin. By SPSS software, all model rats were divided into model group, herbal group, Metformin group, besides, normal group was added, 10 rats in each group. After treatment, the blood glucose, insulin and lipids were tested; the pancreatic β cell apoptosis was examined by terminal-deoxynucleoitidyl transferase mediated nick end labeling method; and scrib protein expression was detected by Western blot in extracted and purified pancreatic islet cells. Results Compared with model group, the levels of fasting blood-glucose, 2 h postprandial blood glucose, fasting insulin, 2 h postprandial insulin, insulin resistance index and total cholesterol, triacylglycerol, low density lipoprotein cholesterin in herbal group and Metformin group were all decreased, the differences were statistically significant (P < 0.05 or P < 0.01), while high density lipoprotein cholesterol had no obvious changes, the difference was not statistically significant (P > 0.05). Compared with model group, the β cell apoptosis indices in herbal group and Metformin group were also decreased (P < 0.01), meanwhile, the scrib protein expression in islet cells was increased significantly (P < 0.01). Conclusion Huoxue Jiangtang Decoction treatment has the effects of regulating blood lipid, decreasing blood glucose, improving insulin resistance, which can effectively prevent β cell apoptosis. The mechanism may be related to the upregulation of scrib protein expression in islet cells.
[Key words] Huoxue Jiangtang Decoction; Type 2 diabetes mellitus; Cell apoptosis; Scrib; Hippo pathway
生活水平提高和飲食結(jié)構(gòu)改變導(dǎo)致我國2型糖尿?。═2DM)發(fā)病率逐年增加[1-2]。在T2DM的進(jìn)展過程中,β細(xì)胞凋亡是重要的病理生理過程之一[3-4]。導(dǎo)致β細(xì)胞凋亡的原因眾多,近期研究發(fā)現(xiàn),scrib蛋白可通過Hippo信號通路發(fā)揮抗凋亡作用[5-6],筆者前期研究發(fā)現(xiàn),T2DM大鼠胰腺scrib蛋白表達(dá)下調(diào),可能是導(dǎo)致β細(xì)胞凋亡的原因之一[7]。目前針對β細(xì)胞凋亡的防治手段非常有限,因此,有必要開發(fā)具有β細(xì)胞保護(hù)作用的藥物。活血降糖飲是深圳市中醫(yī)院內(nèi)分泌科協(xié)定處方,具有益氣養(yǎng)陰、活血通絡(luò)的作用,筆者前期研究提示其具有良好的降糖調(diào)脂作用[7]。本研究建立T2DM大鼠模型,進(jìn)一步探討活血降糖飲對β細(xì)胞凋亡的防治作用和對scrib蛋白表達(dá)的影響。
1 材料與方法
1.1 實驗動物
實驗動物購自廣州中醫(yī)藥大學(xué)實驗動物中心,50只(合格證號:44002100006561),約2月齡,體重180 g左右,雄性SD大鼠(SPF級)。飼養(yǎng)環(huán)境:溫度18~22℃,濕度40%~70%,自由攝食、飲水,自然晝夜節(jié)律光照。常規(guī)對照飼料(熱量構(gòu)成:脂肪13%,蛋白質(zhì)23%,碳水化合物64%)及高脂飼料(熱量構(gòu)成:脂肪60%,蛋白質(zhì)20%,碳水化合物20%)均購于廣東省醫(yī)學(xué)實驗動物中心。
1.2 實驗藥物
活血降糖飲制劑的準(zhǔn)備按本課題組前期研究中所采用的方法準(zhǔn)備[7],二甲雙胍為中美上海施貴寶出品(商品名:格華止,AAP0010),用蒸餾水溶解,調(diào)整濃度至20 mg/mL,4℃儲存。
1.3 試劑與儀器
血糖、總膽固醇(TC)、三酰甘油(TG)、低密度脂蛋白膽固醇(LDL-C)、高密度脂蛋白膽固醇(HDL-C)試劑盒均購自南京建成生物工程研究所(F006、F002、A110-1、A113-1、A112-1);胰島素放免試劑盒購于北京原子能科學(xué)研究所(YB-10069);鏈脲佐菌素(STZ)、Histopaque、Cy3標(biāo)記的抗兔IgG購自Sigma公司(S0130、10771、C2821);小牛血清購于美國GIBICO公司(10100147);膠原酶P、TUNEL試劑盒購于羅氏公司(Roche)(11213865001、11684795910);兔抗大鼠胰島素、scrib、β-actin多克隆抗體購自Santa Cruz公司(sc-28737、sc-10731);蛋白抽提試劑盒及辣根過氧化物酶標(biāo)記的山羊抗兔IgG抗體購自武漢博士德公司(AR0101、BA1054)。
主要檢測儀器采用DYCZ-24型垂直板電泳槽(北京六一儀器廠)和LSM700激光共聚焦顯微鏡(德國蔡司公司)。
1.4 方法
1.4.1 實驗動物模型和分組 經(jīng)過1周的適應(yīng)性喂養(yǎng)后,隨機選出10只大鼠作為正常組,標(biāo)準(zhǔn)飼料喂養(yǎng),自由進(jìn)食進(jìn)水。以高脂高熱卡飲食喂養(yǎng)其余大鼠,4周后,模型組大鼠按30 mg/kg劑量尾靜脈注射用檸檬酸緩沖液配制的2% STZ溶液,1周后,各組大鼠均行口服葡萄糖耐量試驗(OGTT),檢測空腹血糖(FPG)及餐后2 h血糖(2 h PBG),通過正常組大鼠計算FPG、2 h PBG 95%可信區(qū)間,F(xiàn)PG、2 h PBG均高于正常范圍上限20%認(rèn)為T2DM模型成功,應(yīng)用SPSS軟件將造模成功的30只大鼠隨機分為模型組、中藥組、雙胍組,加上正常組共四組,每組各10只。
1.4.2 動物處理 正常組和模型組以等體積生理鹽水灌胃,中藥組灌服活血降糖飲煎劑,劑量為5 g/(kg·d)(按生藥質(zhì)量換算),雙胍組以200 mg/(kg·d)劑量治療。治療期間正常組喂以常規(guī)飼料,其他組均繼續(xù)喂以高脂高熱卡飼料。各組均治療8周后,行OGTT,檢測FPG、2 h PBG、空腹胰島素(FINS)、餐后2 h胰島素(2 h INS),1周后,禁食24 h,腹腔注射麻醉(戊巴比妥鈉45 mg/kg)后,腹主動脈取血,分離血清檢測血脂,各組隨機選取3只大鼠取胰腺組織,4%多聚甲醛固定,石蠟包埋切片;另外7只大鼠通過原位灌注法分離胰島細(xì)胞,用于檢測scrib蛋白表達(dá)。
1.5 觀察指標(biāo)
①按照試劑盒說明書檢測各血清學(xué)指標(biāo)。②TUNEL法檢測胰島β細(xì)胞凋亡:嚴(yán)格按照試劑盒說明書操作。③胰島細(xì)胞分離和純化:按參考文獻(xiàn)[8]的方法分離胰島,大鼠取血后,經(jīng)膽總管注射0.75 mg/mL膠原酶P(4℃預(yù)冷)10 mL(pH 7.6~7.8,Ca2+ 7.5 mmol/L,HEPES 10 mmol/L),迅速摘取膨脹的胰腺,置于Hank液中,38℃消化10 min,加入4℃ Hank液(含10%小牛血清)終止消化,過600 μm鋼篩后,Hank液重懸,4℃,1000 r/min離心2 min(r = 144 mm)洗滌×2次后,4℃,3000 r/min,20 min(r = 144 mm),Histopaque梯度離心純化胰島,取中間界面的胰島細(xì)胞,4℃ Hank液1000 r/min離心2 min(r = 144 mm)洗滌2次備用。④Western blot檢測胰島細(xì)胞scrib蛋白表達(dá):分離純化的胰島細(xì)胞按按照蛋白抽提試劑盒說明書操作提取總蛋白,考馬斯亮藍(lán)G-250測定蛋白濃度;10% SDS-PAGE凝膠電泳(各樣品上樣量均為50 μg),濕轉(zhuǎn)法轉(zhuǎn)膜后,封閉2 h,4℃孵育過夜(抗體工作濃度為1∶1000),第2天TBST洗膜后用二抗孵育2 h(二抗工作濃度為1∶5000)后,進(jìn)行雜交ECL化學(xué)發(fā)光。分析每條帶的吸光度值,用蛋白/內(nèi)參(β-actin)的比值表示各蛋白的相對表達(dá)量。
1.6 統(tǒng)計學(xué)方法
統(tǒng)計學(xué)分析采用SPSS 22.0軟件,計量資料以均數(shù)±標(biāo)準(zhǔn)差(x±s)表示,各組間差異采用單因素方差分析(one way ANOVA),組間多重比較,使用Bonferroni檢驗,以P < 0.05為差異有統(tǒng)計學(xué)意義。
2 結(jié)果
2.1 各組大鼠血糖、胰島素及胰島素抵抗指數(shù)(HOMA-IR)比較
與正常組比較,模型組FPG、2 h PBG、FINS、2 h INS、HOMA-IR均明顯升高,差異有高度統(tǒng)計學(xué)意義(P < 0.01)。與模型組比較,中藥組、雙胍組FPG、2 h PBG、FINS、2 h INS、HOMA-IR均明顯下降,差異有統(tǒng)計學(xué)意義(P < 0.05或P < 0.01)。見表1。
2.2 各組大鼠血脂水平比較
與正常組比較,模型組TC、TG、LDL-C均明顯升高,HDL-C明顯下降,差異有高度統(tǒng)計學(xué)意義(P < 0.01)。與模型組比較,中藥組、雙胍組TC、TG、LDL-C均明顯降低,差異有高度統(tǒng)計學(xué)意義(P < 0.01),而HDL-C無明顯變化,差異無統(tǒng)計學(xué)意義(P > 0.05)。見表2。
2.3 各組大鼠β細(xì)胞凋亡情況比較
激光共聚焦顯微鏡下觀察,紅色熒光為胰島β細(xì)胞,綠色熒光為凋亡細(xì)胞,紅色熒光和綠色熒光重疊為凋亡的β細(xì)胞。每張切片隨機選取4個視野,計數(shù)每個視野胰島中標(biāo)記的陽性凋亡細(xì)胞數(shù)及胰島細(xì)胞總數(shù)。根據(jù)凋亡細(xì)胞數(shù)占胰島總細(xì)胞核數(shù)百分比計算凋亡指數(shù)(AI),取平均值。正常組β細(xì)胞凋亡較少(圖1A~C,封三);模型組β細(xì)胞凋亡細(xì)胞明顯增多(圖1D~F,封三);中藥組、雙胍組β細(xì)胞凋亡較模型組明顯減少(圖1G~L,封三)。由圖1M(封三)所見,模型組β細(xì)胞凋亡指數(shù)明顯高于正常組(P < 0.01),而各治療組胰島β細(xì)胞凋亡指數(shù)明顯低于模型組(P < 0.05)。
2.4 各組大鼠胰島β細(xì)胞scrib蛋白表達(dá)情況
圖2為提取純化的β細(xì)胞。與正常組比較,模型組scrib蛋白表達(dá)明顯下降(P < 0.01),而與模型組比較,中藥組和雙胍組scrib蛋白表達(dá)均明顯上調(diào),差異有高度統(tǒng)計學(xué)意義(P < 0.01)。見圖3。
3 討論
細(xì)胞凋亡是細(xì)胞死亡的一種方式,中醫(yī)理論對死亡的認(rèn)識大多認(rèn)為“陰陽離決,精氣乃絕”,從維持陰陽平衡以維持生命活動和陰陽相互關(guān)系來看,“陰者,藏精氣而其亟也”,說明陰精是人體生命活動的物質(zhì)基礎(chǔ),《黃帝內(nèi)經(jīng)》中亦有云:“奉陰者壽,任陽者夭?!奔?xì)胞是人體的組成部分,細(xì)胞的生死與人的生老病死息息相關(guān),如β細(xì)胞的大量死亡則會導(dǎo)致糖尿病的發(fā)生,結(jié)合經(jīng)典的“三消”理論,應(yīng)用中醫(yī)理論辨治糖尿病應(yīng)以益氣養(yǎng)陰為大法。
活血降糖飲是本課題組所在國家重點??茀f(xié)定處方,由黃芪、生地、丹參等中藥組成,具有益氣養(yǎng)陰、活血化瘀的功效。本課題組前期研究表明[9-10],T2DM患者除血糖外,其血TC、TG較正常對照組顯著升高,經(jīng)用活血降糖方治療后,F(xiàn)PG、TC均顯著降低。本研究再次提示,活血降糖飲對T2DM動物模型具有良好的降糖調(diào)脂、改善胰島素抵抗的作用,同時,可以改善β細(xì)胞凋亡。
細(xì)胞凋亡的誘發(fā)因素、發(fā)生機制和涉及到的信號途徑眾多,如氧化應(yīng)激與炎癥途徑[11]、內(nèi)質(zhì)網(wǎng)應(yīng)激[12]、Caspase家族、B細(xì)胞淋巴瘤蛋白家族途徑[13]等。而Hippo通路是近年發(fā)現(xiàn)的一條進(jìn)化上保守的信號級聯(lián)通路,它可以通過調(diào)節(jié)細(xì)胞增殖、凋亡、分化和干/祖細(xì)胞命運來控制器官大小[14],此通路活化后抑制細(xì)胞增殖,促進(jìn)細(xì)胞凋亡[15-16]。Yes相關(guān)蛋白(YAP)作為該信號通路重要的核心轉(zhuǎn)錄共激活因子,可通過不同通路促進(jìn)細(xì)胞凋亡[17-18]。scrib屬于腫瘤的腫瘤抑制基因[19],近來,scrib被證明參與Hippo信號轉(zhuǎn)導(dǎo)通路[20-21],研究表明,scrib能與Fat1相互作用抑制YAP在核內(nèi)定位及激活,從而抑制細(xì)胞凋亡[22-23]。
本研究發(fā)現(xiàn),模型組大鼠胰島細(xì)胞scrib蛋白表達(dá)下調(diào),而經(jīng)活血降糖飲治療后,胰島細(xì)胞scrib蛋白表達(dá)上調(diào),這可能是活血降糖飲抑制胰島細(xì)胞凋亡的作用機制之一。在以后的研究中,將進(jìn)一步研究活血降糖飲對Hippo信號通路中其他重要信號分子的調(diào)控作用,以進(jìn)一步闡明活血降糖飲降糖調(diào)脂的作用機制。
[參考文獻(xiàn)]
[1] Wang Z,Adair LS,Cai J,et al. Diet Quality Is Linked to Insulin Resistance among Adults in China [J]. J Nutr,2017, 147(11):2102-2108.
[2] Luo B,Zhang J,Hu Z,et al. Diabetes-related behaviours among elderly people with pre-diabetes in rural communities of Hunan,China:a cross-sectional study [J]. BMJ Open,2018,8(1):e15747.
[3] Chen C,Wu S,Lin X,et al. ERK5 plays an essential role in gestational beta-cell proliferation [J]. Cell Prolif,2017, 51(3):e12410.
[4] Dlamini Z,Mokoena F,Hull R. Abnormalities in alternative splicing in diabetes:therapeutic targets [J]. J Mol Endocrinol,2017,59(2):R93-R107.
[5] Pearson HB,Mcglinn E,Phesse TJ,et al. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis [J]. Mol Cancer,2015,14:169.
[6] Perez E,Lindblad JL,Bergmann A. Tumor-promoting function of apoptotic caspases by an amplification loop involving ROS,macrophages and JNK in Drosophila [J]. Elife,2017,6:e26747.
[7] 劉德亮.血瘀和脂毒與糖脂代謝紊亂的關(guān)系及活血降糖飲的治療作用[D].廣州:廣州中醫(yī)藥大學(xué),2015.
[8] Gotoh M,Maki T,Satomi S,et al. Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection [J]. Transplantation,1987,43(5):725-730.
[9] 李惠林,張志玲,李順民,等.活血降糖方對Ⅱ型糖尿病人紅細(xì)胞膜脂區(qū)流動性的影響[J].陜西中醫(yī)學(xué)院學(xué)報,2000,23(4):44-45.
[10] 張志玲,李惠林,董彥敏,等.活血降糖飲對2型糖尿病代謝及血液流變學(xué)的療效觀察[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2004,10(7):70-71.
[11] Bajaj M,Suraamornkul S,Kashyap S,et al. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes [J]. J Clin Endocrinol Metab,2004,89(9):4649-4655.
[12] Litwak SA,Wali JA,Pappas EG,et al. Lipotoxic Stress Induces Pancreatic beta-Cell Apoptosis through Modulation of Bcl-2 Proteins by the Ubiquitin-Proteasome System [J]. J Diabetes Res,2015,2015:280615.
[13] Lupi R,Dotta F,Marselli L,et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets:evidence that beta-cell death is caspase mediated,partially dependent on ceramide pathway,and Bcl-2 regulated [J]. Diabetes,2002,51(5):1437-1442.
[14] Huang J,Wu S,Barrera J,et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie,the Drosophila Homolog of YAP [J]. Cell,2005,122(3):421-434.
[15] Yeung B,Khanal P,Mehta V,et al. Identification of Cdk1-LATS-Pin1 as a novel signaling axis in anti-tubulin drug response of cancer cells [J]. Mol Cancer Res,2018, 16(6):1035-1045.
[16] Gao Y,Yi J,Zhang K,et al. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in eso-phageal squamous cell carcinoma [J]. J Exp Clin Cancer Res,2017,36(1):161.
[17] Li H,He F,Zhao X,et al. YAP Inhibits the Apoptosis and Migration of Human Rectal Cancer Cells via Suppression of JNK-Drp1-Mitochondrial Fission-HtrA2/Omi Pathways [J]. Cell Physiol Biochem,2017,44(5):2073-2089.
[18] Andrade D,Mehta M,Griffith J,et al. YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways [J]. Oncotarget,2017,8(58):98495-98508.
[19] Humbert P,Russell S,Richardson H. Dlg,Scribble and Lgl in cell polarity,cell proliferation and cancer [J]. Bioessays,2003,25(6):542-553.
[20] 劉紅媛,馬南希,馬瑞,等.Roux-en-Y胃旁路術(shù)對2型糖尿病大鼠肝及外周胰島素敏感性的影響[J].中國實驗動物學(xué)報,2017,25(3):270-274.
[21] Doggett K,Grusche FA,Richardson HE,et al. Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling [J]. BMC Dev Biol,2011,11:57.
[22] 上官若男,朱斌,尚畫雨,等.改善Ⅱ型糖尿病大鼠糖代謝運動模型的建立[J].中國實驗動物學(xué)報,2017,25(3):275-280.
[23] Skouloudaki K,Puetz M,Simons M,et al. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development [J]. Proc Natl Acad Sci USA,2009,106(21):8579-8584.
(收稿日期:2018-03-16 本文編輯:張瑜杰)